Update:
On November 7, 2025, the National Comprehensive Cancer Network (NCCN) updated its Prostate Cancer guidelines. The GPSs positioned within the guidelines have remained unchanged. We are aware of the conflicting messaging employed by our competitors against GPS.
We have drafted a concise summary of the changes and talking points to facilitate your ability to address any potential misunderstandings. We will schedule a team call to discuss the messaging and address any lingering questions.
Thank you!
